Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leigh Perreault

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
JAMA|October 27, 2025
Artificial Intelligence and Diabetes PreventionLeigh Perreault
The American Journal of Medicine|May 21, 2017
EMPA-REG OUTCOME: The Endocrinologist's Point of ViewLeigh Perreault
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 6, 2018
GOALS FOR MEDICAL TREATMENT IN OBESITY AND PREDIABETES: IMPROVING OUTCOMES FOR BOTHLeigh Perreault
The American Journal of Cardiology|June 14, 2017
EMPA-REG OUTCOME: The Endocrinologist's Point of ViewLeigh Perreault
Journal of Diabetes and Its Complications|December 18, 2013
Approaching pre-diabetesLeigh Perreault, Kristine Færch
The New England Journal of Medicine|May 27, 2025
Overweight and Obesity - Capturing the Whole PictureVanita R Aroda, Leigh Perreault
Journal of Diabetes|November 21, 2023
Out of stock: A brief clinical reference for rough equivalency of glucagon-like peptide-1 (GLP-1) ± glucose-dependent insulinotropic polypeptide (GIP) receptor agonists for A1c and weight reduction in people with type 2 diabetesLeigh Perreault, Bryan C Bergman
Plos One|June 22, 2012
Does insulin resistance drive the association between hyperglycemia and cardiovascular risk?Kristine Færch, Bryan Bergman, Leigh Perreault
Advances in Therapy|February 14, 2019
The Association Between Type 2 Diabetes and Cardiovascular Disease: The "For Your SweetHeart™" SurveyLeigh Perreault, Marilyn K Boardman, Jonathan Pak
Nature Reviews. Endocrinology|May 5, 2021
Novel therapies with precision mechanisms for type 2 diabetes mellitusLeigh Perreault, Jay S Skyler, Julio Rosenstock
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
JAMA|October 27, 2025
Artificial Intelligence and Diabetes PreventionLeigh Perreault
The American Journal of Medicine|May 21, 2017
EMPA-REG OUTCOME: The Endocrinologist's Point of ViewLeigh Perreault
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 6, 2018
GOALS FOR MEDICAL TREATMENT IN OBESITY AND PREDIABETES: IMPROVING OUTCOMES FOR BOTHLeigh Perreault
The American Journal of Cardiology|June 14, 2017
EMPA-REG OUTCOME: The Endocrinologist's Point of ViewLeigh Perreault
Journal of Diabetes and Its Complications|December 18, 2013
Approaching pre-diabetesLeigh Perreault, Kristine Færch
The New England Journal of Medicine|May 27, 2025
Overweight and Obesity - Capturing the Whole PictureVanita R Aroda, Leigh Perreault
Journal of Diabetes|November 21, 2023
Out of stock: A brief clinical reference for rough equivalency of glucagon-like peptide-1 (GLP-1) ± glucose-dependent insulinotropic polypeptide (GIP) receptor agonists for A1c and weight reduction in people with type 2 diabetesLeigh Perreault, Bryan C Bergman
Plos One|June 22, 2012
Does insulin resistance drive the association between hyperglycemia and cardiovascular risk?Kristine Færch, Bryan Bergman, Leigh Perreault
Advances in Therapy|February 14, 2019
The Association Between Type 2 Diabetes and Cardiovascular Disease: The "For Your SweetHeart™" SurveyLeigh Perreault, Marilyn K Boardman, Jonathan Pak
Nature Reviews. Endocrinology|May 5, 2021
Novel therapies with precision mechanisms for type 2 diabetes mellitusLeigh Perreault, Jay S Skyler, Julio Rosenstock
Pageof 11